Caxton Associates (UK)’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$235K Buy
+5,271
New +$190K ﹤0.01% 677
2026
Q1
Sell
-5,700
Closed -$205K 1014
2025
Q4
$205K Buy
+5,700
New +$209K ﹤0.01% 708

Other funds holding VCEL

Caxton Associates (UK)'s VCEL Position: Q2 2026 in Review

Caxton Associates (UK) opened a new position in Vericel Corp (VCEL) in Q2 2026: 5,271 shares worth $235K. The stake represents ﹤0.01% of the portfolio and ranks #677 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in VCEL as recently as Q4 2025.

Caxton Associates (UK) first reported a position in VCEL in Q4 2025 and has held it in 2 quarters since. 320 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • Caxton Associates (UK) held 5,271 shares of Vericel Corp worth $235K as of Q2 2026.
  • Vericel Corp was a new Caxton Associates (UK) position in Q2 2026.
  • Vericel Corp made up ﹤0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #677 holding.
  • Caxton Associates (UK) first reported a position in Vericel Corp in Q4 2025 and has held it in 2 quarters since.
  • 320 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.